{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:18:39Z","timestamp":1783070319785,"version":"3.54.6"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Phakomatoses are a heterogenous group of congenital neurocutaneous syndromes that are associated with a wide range of ocular and systemic presentations. The ocular conditions are important to consider as they may be asymptomatic early on, but progress to irreversible vision loss. Due to the variability of disease presentation, timely diagnosis is crucial to preserve visual outcomes. This article provides a comprehensive review of literature on nine major phakomatoses, including Neurofibromatosis type 1, Neurofibromatosis type 2, Tuberous Sclerosis complex, Sturge Weber syndrome, Von Hippel-Lindau, Ataxia Telangiectasia, Basal Cell Nevus Syndrome, Wyburn-Mason syndrome, and PHACE syndrome, which are commonly treated by ophthalmologists and other eye care professionals. Across these syndromes, some common vision threatening manifestation include glaucoma, optic pathway gliomas, and retinal hamartomas, with variability in the age of onset and disease progression. This article aims to provide syndrome specific screening guidelines to allow early detection of ocular pathology and promote multi-disciplinary care among ophthalmologists, pediatricians, and other providers to decrease visual morbidities and improve overall patient outcomes.<\/jats:p>","DOI":"10.3389\/fcell.2026.1785180","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:46:06Z","timestamp":1783068366000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Ophthalmic screening in phakomatoses"],"prefix":"10.3389","volume":"14","author":[{"given":"Bijal","family":"Kikani","sequence":"first","affiliation":[{"name":"Medical College of Wisconsin","place":["Milwaukee, WI, United States"]},{"name":"SUNY Upstate Medical University, Norton College of Medicine","place":["Syracuse, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Stanley","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin","place":["Milwaukee, WI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Ramasubramanian","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin","place":["Milwaukee, WI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"786519","DOI":"10.1155\/2015\/786519","article-title":"Ophthalmic alterations in the Sturge-Weber Syndrome, Klippel-Trenaunay Syndrome, and the Phakomatosis Pigmentovascularis: an Independent Group of conditions?","volume":"2015","author":"Abdolrahimzadeh","year":"2015","journal-title":"BioMed Res. Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"101653","DOI":"10.1016\/j.arr.2022.101653","article-title":"The hallmarks of aging in Ataxia-Telangiectasia","volume":"79","author":"Aguado","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"B3","first-page":"548","article-title":"Neurofibromatosis type 2","volume":"5","author":"Asthagiri","year":"2009","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/bjo.57.10.773","article-title":"Vitreous haemorrhage in tuberous sclerosis: report of two cases","volume":"57","author":"Atkinson","year":"1973","journal-title":"Br. J. Ophthalmol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s11940-013-0253-6","article-title":"Sturge-Weber Syndrome","volume":"15","author":"Bachur","year":"2013","journal-title":"Curr. Treat. Options Neurology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrneph.2013.144","article-title":"Renal cancer in von Hippel\u2013Lindau disease and related syndromes","volume":"9","author":"Bausch","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/j.amjcard.2013.08.025","article-title":"Congenital cardiac, aortic arch, and vascular bed anomalies in PHACE syndrome (from the International PHACE Syndrome Registry)","volume":"112","author":"Bayer","year":"2013","journal-title":"Am. Journal Cardiology"},{"key":"B8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with Tuberous sclerosis complex or sporadic LAM","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archopht.124.3.379","article-title":"Optic nerve sheath meningiomas in patients with neurofibromatosis type 2","volume":"124","author":"Bosch","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1076\/opge.19.3.123.2185","article-title":"The two-stage mutation model in retinal hemangioblastoma","volume":"19","author":"Chang","year":"1998","journal-title":"Ophthalmic Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/lsm.20529","article-title":"Efficacy of early treatment of facial port wine stains in newborns: a review of 49 cases","volume":"39","author":"Chapas","year":"2007","journal-title":"Lasers Surg. Med."},{"key":"B12","first-page":"495","article-title":"Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations","volume":"103","author":"Chew","year":"2005","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-444-62702-5.00010-X","article-title":"Von Hippel\u2013Lindau disease","volume":"132","author":"Chittiboina","year":"2015","journal-title":"Handb. Clinical Neurology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"101169","DOI":"10.1016\/j.spen.2024.101169","article-title":"Ataxia telangiectasia","volume":"52","author":"Collyer","year":"2024","journal-title":"Seminars Pediatr. Neurology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/08830738030180080701","article-title":"Topical review: pathophysiology of Sturge-Weber Syndrome","volume":"18","author":"Comi","year":"2003","journal-title":"J. Child Neurology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.spen.2015.10.005","article-title":"Current therapeutic options in Sturge-Weber Syndrome","volume":"22","author":"Comi","year":"2015","journal-title":"Seminars Pediatr. Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ophtha.2023.12.014","article-title":"Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease","volume":"131","author":"Daniels","year":"2023","journal-title":"Ophthalmology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1542\/peds.105.3.608","article-title":"Use of the NIH criteria for diagnosis of neurofibromatosis 1 in children","volume":"105","author":"DeBella","year":"2000","journal-title":"Pediatrics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/ICU.0000000000000609","article-title":"Neuro-ophthalmic manifestations of the phakomatoses","volume":"30","author":"Douglas","year":"2019","journal-title":"Curr. Opin. Ophthalmol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.ophtha.2012.01.027","article-title":"Congenital ectropion uvea and mechanisms of glaucoma in neurofibromatosis type 1","volume":"119","author":"Edward","year":"2012","journal-title":"Ophthalmology"},{"key":"B21","volume-title":"Europe PMC. Europepmc.Org","author":"Europe","year":"2016"},{"key":"B22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/jmg.29.12.841","article-title":"A genetic study of neurofibromatosis type 2 in the United Kingdom","volume":"29","author":"Evans","year":"1992","journal-title":"J. Med. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","author":"Evans","year":"","journal-title":"Am. J. Med. Genet. A"},{"key":"B24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmga.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from UK family genetic register service","author":"Evans","year":"","journal-title":"Am. J. Med. Genet. Part A"},{"key":"B25","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/s0002-9394(02)01796-8","article-title":"Ocular manifestations of ataxia-telangiectasia","volume":"134","author":"Farr","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J. Med. Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/neuonc\/nos076","article-title":"Visual outcomes in children with neurofibromatosis type 1\u2013associated optic pathway glioma following chemotherapy","volume":"14","author":"Fisher","year":"2012","journal-title":"Neuro Oncol."},{"key":"B28","first-page":"589","article-title":"Everolimus for SEGA in Tuberous sclerosis complex: \u22655-year outcomes","volume":"52","author":"Franz","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1001\/archderm.132.3.307","article-title":"PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities","volume":"132","author":"Frieden","year":"1996","journal-title":"Archives Dermatology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jpeds.2016.07.054","article-title":"PHACE syndrome: Consensus-Derived diagnosis and care recommendations","volume":"178","author":"Garzon","year":"2016","journal-title":"J. Pediatr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/336577a0","article-title":"Localization of an ataxia-telangiectasia gene to chromosome 11q22\u201323","volume":"336","author":"Gatti","year":"1988","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/jnnp.70.5.644","article-title":"Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system","volume":"70","author":"Glasker","year":"2001","journal-title":"J. Neurology, Neurosurg. and Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5669","DOI":"10.2147\/2FOTT.S190753","article-title":"Von Hippel-Lindau Disease: current Challenges and Future Prospects","volume":"13","author":"Gl\u00e4sker","year":"2020","journal-title":"OncoTargets Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ajo.2020.08.003","article-title":"Facial port-wine stain phenotypes associated with glaucoma risk in neonates","volume":"220","author":"Ha","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.18502\/jovr.v16i3.9438","article-title":"Ocular manifestations of the Sturge\u2013Weber Syndrome","volume":"16","author":"Hassanpour","year":"2021","journal-title":"J. Ophthalmic Vis. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/STROKEAHA.107.485185","article-title":"The cerebral vasculopathy of PHACES syndrome","volume":"39","author":"Heyer","year":"2008","journal-title":"Stroke"},{"key":"B37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ad.2016.09.022","article-title":"Sturge-Weber Syndrome: a review","volume":"108","author":"Higueros","year":"2017","journal-title":"Actas Sifiliogr."},{"key":"B38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/ceo.12806","article-title":"Hodgson NOphthalmic manifestations of tuberous sclerosis: a review","volume":"45","author":"Hodgson","year":"2017","journal-title":"Clin. Exp. Ophthalmol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.3390\/curroncol31050199","article-title":"Incidence of ophthalmological complications in neurofibromatosis type 1 patients treated with MEK inhibitors","volume":"31","author":"Hummel","year":"2024","journal-title":"Curr. Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000548701","article-title":"Belzutifan for Ocular Tumors in Patients with von Hippel-Lindau Disease","volume":"11","author":"Jamshidi","year":"2025","journal-title":"Ocular Oncol. Pathology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","article-title":"Clinical and genetic aspects of neurofibromatosis 1","volume":"12","author":"Jett","year":"2010","journal-title":"Genet. Med."},{"key":"B42","first-page":"671","article-title":"Prevalence of neurofibromatosis type 1 in Finnish children","volume":"137","author":"Kallionp\u00e4\u00e4","year":"2018","journal-title":"Hum. Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/s0161-6420(92)31789-0","article-title":"Beauchamp GR ocular findings associated with neurofibromatosis type II","volume":"99","author":"Kaye","year":"1992","journal-title":"Ophthalmology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"101152","DOI":"10.1016\/j.spen.2024.101152","article-title":"PHACE syndrome: a review","volume":"51","author":"Keith","year":"2024","journal-title":"Seminars Pediatr. Neurology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/s1042-3680(18)30171-2","article-title":"The phacomatoses","volume":"10","author":"Kerrison","year":"1999","journal-title":"Neurosurg. Clin. N. Am."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08820538.2021.1897851","article-title":"Ophthalmological aspects of von-Hippel\u2013Lindau syndrome","volume":"36","author":"Khan","year":"2021","journal-title":"Seminars Ophthalmol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e1109","DOI":"10.1634\/theoncologist.2020-0069","article-title":"The use of MEK inhibitors in neurofibromatosis type 1\u2013associated tumors and management of toxicities","volume":"25","author":"Klesse","year":"2020","journal-title":"Oncologist"},{"key":"B48","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jaapos.2004.08.012","article-title":"Ocular and systemic manifestations of PHACES (posterior fossa malformations, hemangiomas, arterial anomalies, cardiac defects and coarctation of the aorta, eye abnormalities, and sternal abnormalities or ventral developmental defects) syndrome","volume":"9","author":"Kronenberg","year":"2005","journal-title":"J. Aapos"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet. Med. Official J. Am. Coll. Med. Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/1531-8249(199909)46:3<287::aid-ana3>3.0.co;2-0","article-title":"Ocular motor abnormalities in ataxia telangiectasia","volume":"46","author":"Lewis","year":"1999","journal-title":"Ann. Neurology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/ana.410410204","article-title":"Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic Pathway Glioma Task Force","volume":"41","author":"Listernick","year":"1997","journal-title":"Ann. Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"104538","DOI":"10.1016\/j.ejmg.2022.104538","article-title":"von Hippel-Lindau disease: updated guideline for diagnosis and surveillance","volume":"65","author":"Louise","year":"2022","journal-title":"Eur. J. Med. Genet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/08820530500350712","article-title":"Retinal Capillary Hemangiomas and von Hippel-Lindau Disease","volume":"21","author":"Magee","year":"2006","journal-title":"Seminars Ophthalmology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1001\/jama.277.18.1461","article-title":"Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease","volume":"277","author":"Manski","year":"1997","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"B56","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1001\/archopht.125.3.389","article-title":"Ocular pathologic findings of neurofibromatosis type 2","volume":"125","author":"McLaughlin","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1542\/peds.2009-0082","article-title":"Consensus statement on diagnostic criteria for PHACE syndrome","volume":"124","author":"Metry","year":"2009","journal-title":"PEDIATRICS"},{"key":"B58","first-page":"e645","article-title":"Choroidal nodules and retinal microvascular abnormalities in neurofibromatosis type 1: OCT and near-infrared correlation","volume":"96","author":"Moramarco","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/eye.2012.124","article-title":"Exudative retinal astrocytic hamartoma diagnosed and treated with pars plana vitrectomy and intravitreal bevacizumab","volume":"26","author":"Nakayama","year":"2012"},{"key":"B60","volume-title":"Tuberous sclerosis complex. Genereviews\u00ae","author":"Northrup","year":"2024"},{"key":"B61","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jpeds.2003.12.046","article-title":"Immunodeficiency and infections in ataxia-telangiectasia","volume":"144","author":"Nowak-Wegrzyn","year":"2004","journal-title":"J. Pediatr."},{"key":"B62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264177","article-title":"The natural history of ataxia-telangiectasia (A-T): a systematic review","author":"Petley","year":"2022"},{"key":"B63","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3171\/jns.2001.95.2.0346","article-title":"Associated arteriovenous malformation of the orbit and brain: a case of Wyburn-Mason syndrome without retinal involvement","volume":"95","author":"Ponce","year":"2001","journal-title":"J. Neurosurgery"},{"key":"B64","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0002-9394(14)72210-X","article-title":"Klein JOcular abnormalities in neurofibromatosis type 2","volume":"120","author":"Ragge","year":"1995","journal-title":"Am. J. Ophthalmol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"104359","DOI":"10.1016\/j.ejmg.2021.104359","article-title":"Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: an integrated evaluation of germline and somatic genomic results","volume":"64","author":"Rana","year":"2021","journal-title":"Eur. J. Med. Genet."},{"key":"B66","volume-title":"Neurofibromatosis: Phenotype, Natural History, and Pathogenesis","author":"Riccardi","year":"1991"},{"key":"B67","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1600-0420.2007.00890.x","article-title":"Ocular findings in Norwegian patients with ataxia-telangiectasia: a 5 year prospective cohort study","volume":"85","author":"Riise","year":"2007","journal-title":"Acta Ophthalmol. Scand."},{"key":"B68","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet Journal Rare Diseases"},{"key":"B69","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a membrane-organizing protein causes neurofibromatosis type 2","volume":"363","author":"Rouleau","year":"1993","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/bjo.85.4.420","article-title":"Ophthalmic manifestations of tuberous sclerosis: a population-based study","volume":"85","author":"Rowley","year":"2001","journal-title":"Br. J. Ophthalmol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/jamadermatol.2020.4226","article-title":"Consensus statement for the management and treatment of port-wine birthmarks in Sturge-Weber Syndrome","volume":"157","author":"Sabeti","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B72","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1755-3768.2008.01331.x","article-title":"Intravitreal bevacizumab for macular oedema in tuberous sclerosis","volume":"88","author":"Saito","year":"2010","journal-title":"Acta Ophthalmol. Scand."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.68070","article-title":"Wyburn-Mason syndrome: a narrative review","volume":"16","author":"Shameem","year":"2024","journal-title":"Cureus"},{"key":"B74","first-page":"139","article-title":"Aggressive retinal astrocytomas in Tuberous sclerosis complex","volume":"102","author":"Shields","year":"2004","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"B75","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/0301-4738.154377","article-title":"Review of spectral domain enhanced depth imaging optical coherence tomography of tumors of the choroid","volume":"63","author":"Shields","year":"2015","journal-title":"Indian J. Ophthalmol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1056\/NEJMoa1213507","article-title":"Sturge\u2013Weber Syndrome and port-wine stains caused by somatic mutation in GNAQ","volume":"368","author":"Shirley","year":"2013","journal-title":"N. Engl. Journal Medicine"},{"key":"B77","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/ICU.0000000000000597","article-title":"Ocular manifestations of Sturge\u2013Weber syndrome","volume":"30","author":"Silverstein","year":"2019","journal-title":"Curr. Opin. Ophthalmol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0039-6257(01)00245-4","article-title":"von Hippel\u2013Lindau Disease","volume":"46","author":"Singh","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/s0161-6420(02)01177-6","article-title":"Treatment of retinal capillary hemangioma","volume":"109","author":"Singh","year":"2002","journal-title":"Ophthalmology"},{"key":"B80","article-title":"Wyburn-Mason syndrome","author":"So","year":"2023"},{"key":"B81","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jaapos.2022.01.011","article-title":"Ophthalmic involvement in PHACES syndrome: prevalence, spectrum of anomalies, and outcomes","volume":"26","author":"Soliman","year":"2022","journal-title":"J. Am. Assoc. Pediatr. Ophthalmol. Strabismus"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.oret.2019.07.009","article-title":"Choroidal vascular pattern in cases of Sturge-Weber Syndrome","volume":"3","author":"Surve","year":"2019","journal-title":"Ophthalmol. Retina"},{"key":"B84","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s12311-018-0990-x","article-title":"Past and present of eye movement abnormalities in Ataxia-Telangiectasia","volume":"18","author":"Tang","year":"2018","journal-title":"Cerebellum"},{"key":"B85","doi-asserted-by":"publisher","first-page":"100935","DOI":"10.1016\/j.xops.2025.100935","article-title":"Autonomous artificial intelligence in diabetic retinopathy testing-lessons learned on successful health System adoption","volume":"6","author":"Teng","year":"2025","journal-title":"Ophthalmol. Sci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/jnr.24241","article-title":"Pathophysiology and management of glaucoma associated with phakomatoses","volume":"97","author":"Thavikulwat","year":"2019","journal-title":"J. Neurosci. Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e667","DOI":"10.1111\/aos.12750","article-title":"Choroidal abnormalities in neurofibromatosis type 1 detected by near-infrared reflectance imaging in paediatric population","volume":"93","author":"Vagge","year":"2015","journal-title":"Acta Ophthalmol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ophtha.2011.07.046","article-title":"Choroidal abnormalities detected by near-infrared reflectance imaging as a diagnostic criterion for neurofibromatosis type 1","volume":"119","author":"Viola","year":"2012","journal-title":"Ophthalmology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jpeds.2017.06.055","article-title":"Prenatal risk factors for PHACE syndrome: a Study using the PHACE syndrome international clinical registry and genetic repository","volume":"190","author":"Wan","year":"2017","journal-title":"J. Pediatr."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1086\/302037","article-title":"An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease evidence for modifier effects","volume":"63","author":"Webster","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"B91","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/13816810.2014.886265","article-title":"Genotype-phenotype Correlations, and Retinal Function and Structure in von Hippel-Lindau Disease","volume":"35","author":"Wittstr\u00f6m","year":"2014","journal-title":"Ophthalmic Genet."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1785180\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:46:10Z","timestamp":1783068370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1785180\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":90,"alternative-id":["10.3389\/fcell.2026.1785180"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1785180","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"article-number":"1785180"}}